Real-world health care costs of relapsed/refractory multiple myeloma during the era of novel cancer agents

Nav

General Info

Geography

Netherlands (NLD)

Time period covered

01/2001 - 12/2009

Data type

Scientific literature

Keywords

Chemotherapy, Health care costs, Multiple myeloma

Citation

Authors

Gaultney JG, Franken MG, Tan SS, Redekop WK, Huijgens PC, Sonneveld P, Uyl-de Groot CA

Journal

J Clin Pharm Ther

Volume

Issue

Pages

41-7

Publication year

2013

Suggested citation

Gaultney JG, Franken MG, Tan SS, Redekop WK, Huijgens PC, Sonneveld P, Uyl-de Groot CA. Real-world health care costs of relapsed/refractory multiple myeloma during the era of novel cancer agents. J Clin Pharm Ther. 2013; 38(1): 41-7.

DOI

10.1111/jcpt.12020

PMID

23126374

GHDx Entry last modified on: Mar 19, 2021

Header sites

Search form

Main menu

Real-world health care costs of relapsed/refractory multiple myeloma during the era of novel cancer agents

Nav